Treatment of Intermittent Claudication by G-CSF-mobilized PB-MNC
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This study will investigate the efficacy of G-CSF mobilized mononuclear cell injection of
patients with PAD who presented with intermittent claudication. Forty PAD patients who
presented with intermittent claudication will be randomized into 2 groups. The control group
will be treated by medication and walking exercise 3 times/ week. The experiment group will
be injected G-CSF mobilized mononuclear cell ,medication and walking exercise 3 times/ week.
Ankle brachial index(ABI), Toe brachial index (TBI) and transcutaneous oxygen measurement
will be evaluated at the day of randomization, 1 , 3, 6 and 12 months